Drug reference
nirsevimab-alip
Monoclonal antibody (for RSV prevention)
Monoclonal antibody (for RSV prevention)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Nirsevimab-alip is a human monoclonal antibody that targets the prefusion form of the RSV F protein.
Related guidelines
Other Unclassified drugs
Ask House about nirsevimab-alip
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team